Deutsches Referenzzentrum für Ethik in den Biowissenschaften (DRZE)

Titel: 6. Symposium Health Technology Assessment: Schwerpunkt Biomedizin / The 6th Symposium Health Technology Assessment: Focus Biomedical Sciences - International experts in discussion

Termin: 3.11.2005, 9:30 Uhr, bis 4.11.2005, 17:00 Uhr

Veranstaltungsort:
Renaissance Hotel Köln
Magnusstrasse 20
50672 Cologne

Referenten: Helmut Brand (Bielefeld, Germany) *** Eduardo Briones Pérez de la Blanca (Seville, Spain) *** Helena Dahlgren (Stockholm, Sweden) *** Hans-Peter Dauben (Cologne, Germany) *** Isabelle Durand-Zaleski (Paris, France) *** Robert Francke (Bremen, Germany) *** John Gabbay (Southampton, Great Britain) *** Elisabeth Giesenhagen (Cologne, Germany) *** Ian Gillespie (Paris, France) *** Alicia Granados (Copenhagen, Denmark) *** Rainer Hess (Cologne, Germany) *** Marlene Fabricius Jensen (Copenhagen, Denmark) *** Dietrich Kaiser (Cologne, Germany) *** Jos Kleijnen (York, Great Britain) *** Finn Børlum Kristensen (Copenhagen, Denmark) *** Krzysztof Landa (Cracow, Poland) *** Berit Mørland (Oslo, Norway) *** Mercia Page (London, Great Britain) *** Alric Rüther (Cologne, Germany) *** Stefan Sauerland (Cologne, Germany) *** Friedrich Wilhelm Schwartz (Hannover, Germany) *** Claudia Wild (Vienna, Austria) *** Niels Wuergeler-Hanson (Copenhagen, Denmark)

Weitere Informationen:
http://www.dimdi.de/static/de/hta/symposien/

Kurzbeschreibung: This year, the German Agency for HTA at DIMDI looks back at five years of active HTA work. Five years in which Health
Technology Assessment has prospered from a special term used by experts to an internationally discussed concept, which in many cases found its way in legislation already. Enough reasons to
examine the knowledge, value and prospects of HTA together with HTA experts from all over the world at the meanwhile sixth German HTA symposium.

With ”Biomedical Sciences“ a focus has been chosen which addresses all aspects of the HTA concept by its political
explosiveness and scientific development. Not only genetic therapies or diagnostic developments may raise many questions concerning efficacy, safety, appropriateness and effectiveness; ethical and legal implications are of great importance here as well.

We want to learn about the experiences and procedures of international HTA organisations and to discuss future measures and challenges. Top-class representatives of European HTA
institutions, of HTA networks and of the international association HTAi will present their know-how. They are accompanied by participants from politics and science, as well as from
international organisations of the health care system, e.g. the OECD.

Traditionally, this year’s HTA symposium programme is dedicated to the exchange between HTA users and HTA developers.
Accordingly, the symposium will be followed by the module for education and training; this year it concerns the evaluation of trials and the use of international information sources.

We are very pleased to be offering you a wide-ranging and interesting programme this year and wish you two inspiring days in Cologne.

Kontakt: DIMDI German Institute of Medical
Documentation and Information
Waisenhausgasse 36 – 38 a
50676 Köln (Cologne)
Tel.: +49 - (0)221 - 4 72 45 25
Fax: +49 - (0)221 - 4 72 44 44
dahta@dimdi.de
http://www.dimdi.de/

Veranstalter: German Agency for Health Technology Assessment, German Institute of Medical Documentation and Information, Federal Ministry of Health and Social Security

Schlagworte: Biotechnologie, Gesundheitswesen, Medizinische Ethik

Artikelaktionen